Trials / Sponsors / Bio Sidus SA
Bio Sidus SA
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease Fabry Disease | Phase 3 | 2022-12-13 |
| Completed | PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV In Fabry Disease | Phase 1 | 2021-10-23 |
| Completed | Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease Anemia of Chronic Kidney Disease | Phase 3 | 2018-02-28 |
| Completed | Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volun Anemia | Phase 1 | 2016-09-01 |
| Unknown | Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo Postmenopausal Osteoporosis With Pathological Fracture | Phase 4 | 2013-06-01 |
| Completed | Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia Antineoplastic Chemotherapy Induced Anemia | Phase 4 | 2011-06-01 |